Discover how [(18)F]YC-88, a revolutionary PSMA-targeting radiotracer, provides unprecedented clarity in prostate cancer detection with rapid clearance from healthy tissues.
Exploring drug repurposing strategies targeting M2 macrophages in castration-resistant prostate cancer bone metastases through transcriptomics and network analysis.
Discover how 99mTc-labelled low molecular weight inhibitors are transforming prostate cancer detection through precise PSMA targeting and SPECT imaging.